Abstract OBJECTIVE: To inquire into the relationship between lipoprotein lipase (LPL) gene D9N, N291S and S447X polymorphisms and the development of cardiovascular diseases in children with obesity. METHODS: The polymerase chain reaction (PCR) and restriction fragment length polymorphism (RLFP) techniques were used to detect three common mutations of LPL gene exon D9N, N291S and S447X in 157 obese children and 175 normal controls. Plasma lipid and lipoprotein levels between children with different genotypes were compared. RESULTS: The D9N and N291S gene mutations were not detected in either the obese or the control groups. There were no significant differences in the frequency of S447X gene mutation between the two groups. There were no significant differences in the levels of plasma lipid and lipoprotein between children with S447 and X447 genotypes. CONCLUSIONS: D9N and N291S gene mutations may not be risk factors associated with cardiovascular diseases in children with obesity. S447X gene mutation might not play an important role in the development of cardiovascular diseases in childhood.［Chin J Contemp Pediatr, 2010, 12 (3):161-164］
GUAN Yu-Ming,GUI Yong-Hao,LUO Fei-Hong et al. Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity[J]. 中国当代儿科杂志, 2010, 12(3): 161-164.
GUAN Yu-Ming,GUI Yong-Hao,LUO Fei-Hong et al. Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity[J]. CJCP, 2010, 12(3): 161-164.
［1］Stettler N, Zemel BS, Kumanyika S, Stallings VA. Infant weight gain and childhood overweight status in a multicenter, cohort study［J］. Pediatrics, 2002, 109(2):194-199.
［2］Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study［J］. N Engl J Med, 1998, 338(23):1650-1656.
［3］Santamarina-Fojo S, Dugi KA. Structure, function and role of lipoprotein lipase in lipoprotein metabolism［J］. Curr Opin Lipidol, 1994, 5(2):117-125.
［4］Oka K, Tkalcevic GT, Nakano T, Tucker H, Ishimura-Oka K, Brown WV. Structure and polymorphic map of human lipoprotein lipase gene［J］. Biochim Biophys Acta, 1990, 1049(1):21-26.
［5］Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS)［J］. Arterioscler Thromb Vasc Biol, 1998, 18(4):526-534.
［7］Fisher RM, Humphries SE, Talmud PJ. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis［J］. Atherosclerosis, 1997, 135(2):145-159.
［8］Gerdes C, Fisher RM, Nicaud V, Boer J, Humphries SE, Talmud PJ, et al. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies［J］. Circulation, 1997, 96(3):733-740.
［9］Mailly F, Tugrul Y, Reymer PW, Bruin T, Seed M, Groenemeyer BF, et al. A common variant in the gene for lipoprotein lipase (Asp9→Asn). Functional implications and prevalence in normal and hyperlipidemic subjects［J］. Arterioscler Thromb Vasc Biol, 1995, 15(4):468-478.
［10］Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, et al. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults［J］. J Lipid Res, 1995, 36(10):2104-2112.
［11］Jukema JW, van Boven AJ, Groenemeijer B, Zwinderman AH, Reiber JH, Bruschke AV, et al. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study［J］. Circulation, 1996, 94(8):1913-1918.
［12］Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease［J］. J Clin Invest, 1997, 99(7):1606-1613.
［13］Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, Boerwinkle E, Berenson GS. Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study［J］. Atherosclerosis, 2001, 159(2):367-373.
［14］Snieder H, van Doornen LJP, Boomsma DI. Dissecting the genetic architecture of lipids, lipoproteins, and apolipoproteins: lessons from twin studies［J］. Arterioscler Thromb Vasc Biol, 1999, 19(12):2826-2834.
［15］Jarvik GP, Goode EL, Austin MA, Auwerx J, Deeb S, Schellenberg GD, et al. Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: a longitudinal analysis［J］. Am J Hum Genet, 1997, 61(1):171-181.
［16］Sawano M, Watanabe Y, Ohmura H, Shimada K, Daida H, Mokuno H, et al. Potentially protective effects of the Ser447-Ter mutation of the lipoprotein lipase gene against the development of coronary artery disease in japanese subjects via a beneficial lipid profile［J］. Jpn Circ J, 2001, 65(4):310-314.
